Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

被引:0
|
作者
Michael V. Chiorean
Jessica R. Allegretti
Puza P. Sharma
Benjamin Chastek
Leonardo Salese
Elizabeth J. Bell
Jesse Peterson-Brandt
Joseph C. Cappelleri
Xiang Guo
Nabeel Khan
机构
[1] Swedish Medical Center,Perelman School of Medicine
[2] Brigham and Women’s Hospital,undefined
[3] Pfizer Inc,undefined
[4] Optum Life Sciences,undefined
[5] HEOR,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
[8] University of Pennsylvania,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, Loriane
    Stefanescu, Carmen
    Vaysse, Thibaut
    Laharie, David
    Roblin, Xavier
    Rosa, Isabelle
    Treton, Xavier
    Abitbol, Vered
    Amiot, Aurelien
    Bouguen, Guillaume
    Dib, Nina
    Fumery, Mathurin
    Pariente, Benjamin
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Simon, Marion
    Viennot, Stephanie
    Bouhnik, Yoram
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (03) : 268 - 273
  • [32] Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
    Vong, Camille
    Martin, Steven W.
    Deng, Chenhui
    Xie, Rujia
    Ito, Kaori
    Su, Chinyu
    Sandborn, William J.
    Mukherjee, Arnab
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (03): : 229 - 240
  • [33] TOFACITINIB IN ULCERATIVE COLITIS: EARLY REAL-WORLD EXPERIENCE IN SOUTHAMPTON
    Young, David
    Ventress, Esther
    Harris, Richard
    McDonnell, Martin
    Bettey, Marion
    Gwiggner, Markus
    Felwick, Richard
    Smith, Trevor
    Cummings, Fraser
    GUT, 2021, 70 : A130 - A130
  • [34] Tofacitinib in Moderate to Severe Ulcerative Colitis patients naive to biological therapy: A prospective real world analysis of efficacy and safety
    Banerjee, R.
    Dhanush, M.
    Raghunathan, N.
    Pal, P.
    Joshi, V.
    Patel, R.
    Godbole, S.
    Akki, Y.
    Valluri, S.
    Nagasuri, P.
    Haridas, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1323 - I1325
  • [35] REAL WORLD EFFECTIVENESS OF TOFACITINIB FOR MODERATE TO SEVERE ULCERATIVE COLITIS: A MULTI-CENTRE UK EXPERIENCE
    Honap, Sailish
    Chapman, Thomas P.
    Chee, Desmond
    Patel, Mehul
    Kent, Alexandra
    Hayee, Bu
    Dubois, Patrick
    Medcalf, Lucy
    Sharma, Esha
    Begum, Yesmina
    Ray, Shuvra
    Kennedy, James
    Cripps, Sarah
    Gordon, Claire
    Walsh, Alissa
    Goodhand, James
    Ahmad, Tariq
    Satsangi, Jack
    Irving, Peter M.
    Kennedy, Nicholas A.
    GASTROENTEROLOGY, 2020, 158 (06) : S1207 - S1207
  • [36] Characteristics of Patients Treated with Tofacitinib for Ulcerative Colitis in the Real World: Findings from a Large US Claims Database
    Clarissa, Almeida
    Fauze, Maluf
    Adriano, Fachin
    Maristela, Almeida
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S5 - S5
  • [37] Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States
    Long, Millie D.
    Smith, Timothy W.
    Dibonaventura, Marco
    Gruben, David
    Bargo, Danielle
    Salese, Leonardo
    Quirk, Daniel
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (06) : 941 - 948
  • [38] REAL-WORLD DOSE ESCALATION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW OF LITERATURE
    Singh, Harpreet
    Pandey, Anuja
    Wilson, Liam
    Tencer, Tom
    Kumar, Jinender
    GASTROENTEROLOGY, 2021, 160 (06) : S26 - S26
  • [39] Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry
    Chaparro, M.
    Garre, A.
    Mesonero, F.
    Rodriguez, C.
    Barreiro-de Acosta, M.
    Martinez-Cadilla, J.
    Arroyo, M. T.
    Mancenido, N.
    Sierra-Ausin, M.
    Vera-Mendoza, I.
    Casanova, M. J.
    Nos, P.
    Gonzalez-Munoza, C.
    Martinez, T.
    Bosca-Watts, M.
    Busquets, D.
    Calafat, M.
    Girona, E.
    Llao, J.
    Martin-Arranz, M. D.
    Piqueras, M.
    Ramos, L.
    Suis, G.
    Bermejo, F.
    Carbajo, A. Y.
    Casas-Deza, D.
    Fernandez-Clotet, A.
    Garcia, M. J.
    Ginard, D.
    Gutierrez-Casbas, A.
    Hernandez-Villalba, L.
    Lucendo, A. J.
    Marquez, L.
    Merino-Ochoa, O.
    Rancel, F. J.
    Taxonera, C.
    Sanroman, A. Lopez
    Rubio, S.
    Domenech, E.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S026 - S028
  • [40] Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry
    Chaparro, Maria
    Garre, Ana
    Mesonero, Francisco
    Rodriguez, Cristina
    Barreiro-de Acosta, Manuel
    Martinez-Cadilla, Jesus
    Arroyo, Maria T.
    Mancenido, Noemi
    Sierra-Ausin, Monica
    Vera-Mendoza, Isabel
    Jose Casanova, Maria
    Nos, Pilar
    Gonzalez-Munoza, Carlos
    Martinez, Teresa
    Bosca-Watts, Maia
    Calafat, Margalida
    Busquets, David
    Girona, Eva
    Llao, Jordina
    Dolores Martin-Arranz, Maria
    Piqueras, Marta
    Ramos, Laura
    Suris, Gerard
    Bermejo, Fernando
    Carbajo, Ana Y.
    Casas-Deza, Diego
    Fernandez-Clotet, Agnes
    Garcia, Maria J.
    Ginard, Daniel
    Gutierrez-Casbas, Ana
    Hernandez, Luis
    Lucendo, Alfredo J.
    Marquez, Lucia
    Merino-Ochoa, Olga
    Rancel, Francisco J.
    Taxonera, Carlos
    Lopez Sanroman, Antonio
    Rubio, Saioa
    Domenech, Eugeni
    Gisbert, Javier P.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (01): : 35 - 42